500 Fifth St, NW
Washington, DC 20001
The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.
Displaying: 1 to 2 of 2 News and Announcements
The California Institute for Regenerative Medicine (CIRM) has achieved many notable results during its first seven years and helped establish the state of California as an international hub of stem cell research and development, says a new report from the Institute of Medicine. However, CIRM's efforts could be enhanced by creating an external scientific advisory board to provide continuing and consistent strategic advice, by dealing more effectively with the perception of conflicts of interest on its governing board, and by reorganizing its governance to ensure that the board is able to provide independent oversight.
The California Institute for Regenerative Medicine (CIRM) asked the Institute of Medicine to conduct an independent review of CIRM's programs and operations and recommend steps to improve its performance. The results of this review appear in a new IOM report, The California Institute for Regenerative Medicine: Science, Governance, and the Pursuit of Cures. Members of the authoring committee will discuss their findings and recommendations in a one-hour telephone press briefing beginning at 1:30 p.m. EST (10:30 a.m. PST) Thursday, Dec. 6.